Ultomiris Euroopan unioni - suomi - EMA (European Medicines Agency)

ultomiris

alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - selektiiviset immunosuppressantit - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

DIB 1.0 g depotlääkevalmiste, emättimeen Suomi - suomi - Fimea (Suomen lääkevirasto)

dib 1.0 g depotlääkevalmiste, emättimeen

syn vet-pharma ireland limited - progesterone - depotlääkevalmiste, emättimeen - 1.0 g - progesteroni

Dinolytic vet. 5 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

dinolytic vet. 5 mg/ml injektioneste, liuos

zoetis animal health aps - dinoprost trometamol - injektioneste, liuos - 5 mg/ml - dinoprosti

Dinolytic vet. 12.5 mg/ml injektioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

dinolytic vet. 12.5 mg/ml injektioneste, liuos

zoetis animal health aps - dinoprost trometamol - injektioneste, liuos - 12.5 mg/ml - dinoprosti

Fyremadel 0,25 mg / 0,5 ml injektioneste, liuos, esitäytetty ruisku Suomi - suomi - Fimea (Suomen lääkevirasto)

fyremadel 0,25 mg / 0,5 ml injektioneste, liuos, esitäytetty ruisku

sun pharmaceutical industries europe b.v. - ganirelix acetate - injektioneste, liuos, esitäytetty ruisku - 0,25 mg / 0,5 ml - ganireliksi

Enstilar 50 mikrog/g + 0,5 mg/g ihovaahto Suomi - suomi - Fimea (Suomen lääkevirasto)

enstilar 50 mikrog/g + 0,5 mg/g ihovaahto

leo pharma a/s - betamethasone dipropionate, calcipotriol hydrate - ihovaahto - 50 mikrog/g + 0,5 mg/g - kalsipotrioli

Betahistine Stada 8 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

betahistine stada 8 mg tabletti

stada arzneimittel ag - betahistine dihydrochloride - tabletti - 8 mg - betahistiini

Betahistine Stada 16 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

betahistine stada 16 mg tabletti

stada arzneimittel ag - betahistine dihydrochloride - tabletti - 16 mg - betahistiini

Betahistine Stada 24 mg tabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

betahistine stada 24 mg tabletti

stada arzneimittel ag - betahistine dihydrochloride - tabletti - 24 mg - betahistiini

Ganirelix Orifarm 0.25 mg / 0.5 ml injektioneste, liuos, esitäytetty ruisku Suomi - suomi - Fimea (Suomen lääkevirasto)

ganirelix orifarm 0.25 mg / 0.5 ml injektioneste, liuos, esitäytetty ruisku

orifarm generics a/s - ganirelix acetate - injektioneste, liuos, esitäytetty ruisku - 0.25 mg / 0.5 ml - ganireliksi